CD160 Expression in Retinal Vessels is Associated With Retinal Neovascular Diseases

NCT03940664 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 75

Last updated 2019-05-07

No results posted yet for this study

Summary

The aims of this study were

* to analyze CD160 expression in both normal and pathological eyes from human adults
* to evaluate association between CD160 presence on endothelial cells from blood vessels and retinal vascular disease

Conditions

  • Surgical Retinal

Interventions

OTHER

immunohistochemistry on Formalin fixed and paraffin embedded blocks

Sponsors & Collaborators

  • CHU de Reims

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-01-31
Primary Completion
2017-01-31
Completion
2017-07-31

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03940664 on ClinicalTrials.gov